Solventum Corp reported 3.21B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Abbott USD 24.47B 1.32B Jun/2025
Align Technology USD 2.45B 46.03M Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Cencora USD 48.81B 1.17B Jun/2025
Dexcom USD 5.03B 476.4M Jun/2025
Insulet USD 2.28B 48.7M Jun/2025
Solventum Corp 3.21B 155M Jun/2025
West Pharmaceutical Services USD 1.68B 223.4M Jun/2025
Zimmer Biomet Holdings USD 5.05B 536.3M Jun/2025